Latest Strategic Initiatives News

Critical Resources Limited has appointed seasoned mining executive Tim Wither as CEO, aiming to leverage his global experience to advance its lithium, antimony, and gold projects.

Global Masters Fund Limited has appointed long-serving director Jason Pohl as its new Managing Director, signaling continuity in leadership and strategic focus.

The NSW Court of Appeal has dismissed an appeal challenging the replacement of Keybridge Capital's directors and confirmed the end of its external administration, marking a pivotal governance shift for the investment group.

NTAW Holdings has terminated its Australian Dunlop tyre distribution agreements, entering new contracts with Sumitomo Rubber Industries and Goodyear entities, while continuing Dunlop distribution in New Zealand. The move marks a strategic pivot as NTAW aims to grow other business units and reduce costs.

NSX Limited has successfully closed a $1.3 million share placement, exceeding its initial $1.1 million target and reinforcing its position as Australia’s second largest exchange.

MedAdvisor Limited has received a non-binding offer from a major multinational software company to acquire its ANZ business division, valuing it above current market expectations.

Nuix Limited has withdrawn its FY25 growth targets due to unpredictable timing in closing large deals, despite maintaining a strong pipeline and confidence in its strategic direction.

88 Energy Limited has secured shareholder approval for a significant capital consolidation, reducing its share count by a factor of 25 effective May 9, 2025. The company has outlined a detailed timetable to guide investors through the transition.

SPC Global Holdings confirms FY2025 pro forma EBITDA guidance of A$29 million, driven by strong early post-merger performance and strategic initiatives including site consolidation and leadership renewal.

Austal Limited has announced a record-breaking $14.2 billion order book, underpinned by strong US and Australian defence contracts, and raised its FY2025 EBIT guidance to at least $80 million.

HMC Capital has unveiled an ambitious plan to grow its assets under management to over $50 billion within the next 3-5 years, supported by strong fundraising and diversified investment verticals. The company’s FY25 outlook remains solid, underpinned by operational growth and strategic initiatives across real estate, digital infrastructure, and energy transition.

Bio-Gene Technology Limited has raised $2.1 million through a placement and launched a Share Purchase Plan to fund critical safety studies for its flagship insecticide Flavocide®, alongside development of Qcide and strategic initiatives.